Literature DB >> 32975845

Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury.

Tuo Yang1,2, Lingyan Xing2, Weiwei Yu2, Yunyun Cai2, Shusen Cui1, Gang Chen3,4.   

Abstract

After spinal cord injury (SCI), the irreversible loss of neurons and the dense glial scar are two of the leading causes of axon regeneration failure. The adult mammalian spinal cord lacks the ability to spontaneously produce new neurons, making it a key challenge to provide new neurons for spinal cord regeneration. Additionally, the dual role of the glial scar (both inhibitory and protective) makes it difficult to manipulate it for therapeutic purposes. In this study, using a single transcription factor Sry-related HMG-box 2 (Sox2) delivered by adeno-associated virus (AAV), we reprogrammed some of the astrocytes targeted by the viral vectors in the glial scar into neurons in a severe SCI model. We show that this astrocytic reprogramming alone can propel axon regeneration by not only replenishing the lost neurons, but also moderately reducing the density of the glial scar without interrupting its integrity. Beyond that, astrocytic reprogramming can significantly improve functional recovery when combined with running wheel rehabilitation, which provides use-dependent plasticity. These findings may provide us with a new idea for how to manipulate the glial scar and a promising therapeutic strategy that combines biological intervention with a rehabilitation strategy.
© 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  astrocytes; cellular reprogramming; neurons; rehabilitation; spinal cord injuries

Year:  2020        PMID: 32975845     DOI: 10.1096/fj.202001657RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  A Protein Composite Neural Scaffold Modulates Astrocyte Migration and Transcriptome Profile.

Authors:  Li Yao; Ryan Brice; Teresa Shippy
Journal:  Macromol Biosci       Date:  2022-01-18       Impact factor: 5.859

Review 2.  Heterogeneity and Molecular Markers for CNS Glial Cells Revealed by Single-Cell Transcriptomics.

Authors:  Junjie Sun; Yixing Song; Zhiheng Chen; Jiaying Qiu; Shunxing Zhu; Liucheng Wu; Lingyan Xing
Journal:  Cell Mol Neurobiol       Date:  2021-10-26       Impact factor: 4.231

Review 3.  Reverse Adverse Immune Microenvironments by Biomaterials Enhance the Repair of Spinal Cord Injury.

Authors:  Hengyi Wang; Yuanliang Xia; Baoqin Li; Yuehong Li; Changfeng Fu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

Review 4.  Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar.

Authors:  Qi-Ming Pang; Si-Yu Chen; Qi-Jing Xu; Sheng-Ping Fu; Yi-Chun Yang; Wang-Hui Zou; Meng Zhang; Juan Liu; Wei-Hong Wan; Jia-Chen Peng; Tao Zhang
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

Review 5.  Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming.

Authors:  Jingyi Wang; Shiling Chen; Chao Pan; Gaigai Li; Zhouping Tang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-07

6.  Knockdown of polypyrimidine tract binding protein facilitates motor function recovery after spinal cord injury.

Authors:  Ri-Yun Yang; Rui Chai; Jing-Ying Pan; Jing-Yin Bao; Pan-Hui Xia; Yan-Kai Wang; Ying Chen; Yi Li; Jian Wu; Gang Chen
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

7.  Integrase deficient lentiviral vector: prospects for safe clinical applications.

Authors:  Chee-Hong Takahiro Yew; Narmatha Gurumoorthy; Fazlina Nordin; Gee Jun Tye; Wan Safwani Wan Kamarul Zaman; Jun Jie Tan; Min Hwei Ng
Journal:  PeerJ       Date:  2022-08-12       Impact factor: 3.061

Review 8.  Planet of the AAVs: The Spinal Cord Injury Episode.

Authors:  Katerina Stepankova; Pavla Jendelova; Lucia Machova Urdzikova
Journal:  Biomedicines       Date:  2021-05-28

9.  Maresin 1 promotes nerve regeneration and alleviates neuropathic pain after nerve injury.

Authors:  Jinhuan Wei; Wenfeng Su; Yayu Zhao; Zhongya Wei; Yuchen Hua; Peng Xue; Xiang Zhu; Ying Chen; Gang Chen
Journal:  J Neuroinflammation       Date:  2022-02-02       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.